Actively Recruiting

Phase 2
Age: 19Years +
All Genders
NCT06458933

Testing Interventions for Borderline Personality Disorder.

Led by York University · Updated on 2026-04-01

304

Participants Needed

1

Research Sites

238 weeks

Total Duration

On this page

Sponsors

Y

York University

Lead Sponsor

C

Centre for Addiction and Mental Health

Collaborating Sponsor

AI-Summary

What this Trial Is About

Borderline personality disorder (BPD) is a life-threatening, costly public health crisis affecting \~1-3% of North Americans, with 10% dying by suicide and annual healthcare costs of \~$63k (Canadian Dollars)/patient. Further, people with BPD's intimate relationships are highly disrupted, and their partners report elevated mental health problems but little access to treatment. Existing BPD treatments are resource-heavy, inaccessible, and 47% of people with BPD do not respond to them. These treatments also neglect relationship problems and intimate partner's mental health concerns, even though they are thought to play a key role in BPD maintenance. BPD interventions may produce stronger, quicker, and more durable outcomes if they incorporated partners to target both the emotional and relationship core of BPD. Moreover, incorporating partners into interventions may improve relationship outcomes and partner mental health without added resource investments. Accordingly, members of our team developed Sage. Named after a plant that thrives in relationship with its ecosystem, Sage is a brief, 12-session conjoint intervention for people with BPD and their intimate partners that targets BPD, relationship conflict, and partner mental health. Our recent uncontrolled trial provides preliminary support for its efficacy. As a next step in testing Sage, it is critical to utilize a Randomized Controlled Trial (RCT) design to identify if Sage is more efficacious than standard care that these couples typically receive; supportive individual psychotherapy (SIP) for people with BPD and their partners. The investigators propose to conduct the first RCT of Sage for couples wherein one member has BPD. The study will examine if Sage is more efficacious than SIP in improving BPD symptoms (primary outcome), as well as relationship conflict and partner mental health (secondary outcomes), as well as a range of other outcomes, from pre- to post-intervention, and post-intervention to follow-up. It will also investigate factors that influence treatment response, BPD severity, and related problems. Up to 152 couples wherein one member has BPD will be randomized to receive Sage or SIP. Gold-standard measures of primary, secondary, and exploratory outcomes will be administered at baseline, mid-intervention, post-intervention, and a one-month, three- month, and six-month follow-up.

CONDITIONS

Official Title

Testing Interventions for Borderline Personality Disorder.

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Participant with borderline personality disorder meets full diagnostic criteria (five or more symptoms) per DSM-5-TR
  • Both members of the couple are at least 19 years old
  • Both members agree to participate in the study
  • Both members agree to emergency contact if safety concerns arise
  • Both members agree to audio and video recording of interviews and sessions
  • Both members live in Ontario and plan to remain there during the study
  • Both members are fluent in English
  • Both members agree to receive study-related emails
  • Both members have regular internet access from a private location for study appointments
Not Eligible

You will not qualify if you...

  • Severe intimate partner violence in the past year
  • Diagnosis of schizophrenia per DSM-5 criteria A and B not explained by BPD
  • Hospitalization for mania in the past year or mania in the past three months
  • Substance or alcohol use disorder likely needing medical detoxification
  • Medical condition likely requiring hospitalization within the next year
  • Impaired intelligence or probable brain injury indicated by low premorbid functioning score
  • Inability to provide proof of identification or accurate contact information during the study
  • Currently receiving empirically-supported BPD treatment and unwilling to pause it during the study

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

York University

Toronto, California, Canada, M3J1P3

Actively Recruiting

Loading map...

Research Team

S

Skye Fitzpatrick, PhD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here